Cirugia y cirujanos最新文献

筛选
英文 中文
[Clinical evolution of patients with infection associated with orthopedic devices in treatment with continuous negative pressure]. [持续负压治疗骨科设备相关感染患者的临床演变]。
Cirugia y cirujanos Pub Date : 2024-02-12 DOI: 10.24875/CIRU.23000248
Jorge Quiroz-Williams, José R Viveros-Encarnación, Suemmy Gaytán-Fernández, Rodolfo G Barragán-Hervella, Carlos R Rueda-Alvarado, América Ramírez-Polanco, M Paloma Martínez-Senda, Andrea M Palma-Jaimes
{"title":"[Clinical evolution of patients with infection associated with orthopedic devices in treatment with continuous negative pressure].","authors":"Jorge Quiroz-Williams, José R Viveros-Encarnación, Suemmy Gaytán-Fernández, Rodolfo G Barragán-Hervella, Carlos R Rueda-Alvarado, América Ramírez-Polanco, M Paloma Martínez-Senda, Andrea M Palma-Jaimes","doi":"10.24875/CIRU.23000248","DOIUrl":"https://doi.org/10.24875/CIRU.23000248","url":null,"abstract":"<p><strong>Objective: </strong>To describe the use of negative pressure therapy with (TPNi) and without instillation (TPNs) as adjuvant treatment in the management of orthopedic device-associated infections (IADO).</p><p><strong>Method: </strong>Analytic observational study of records of patients with IADO managed with TPNi and TPNs with 0.9% saline solution, in patients > 18 years, operated on in 2018-2021. Clinical characteristics of infection, infectious agent as well as sociodemographic variables were evaluated. TPN was performed with the V.A.C. VERAFLO™ system. Analysis with χ2, Fisher and t-Student. Statistically accepted value p < 0.05.</p><p><strong>Results: </strong>Sample 40 patients. 75% male. Fractures 42.5% exposed and 57.5% closed. 92.5% applied prophylactic antibiotic (30-120 min). 35% plate implants, 12.5% centromedullary nail, 10% knee prosthesis and 12.5% hip. 47.5% bleeding < 500 ml. 72.5% surgical time of 2-4 hours. Previous hospitalization time, TPNs 3 weeks 55.9% and 4 weeks 26.5%; TPNi, 3 weeks 50% and 4 weeks 33.3%. Conservation of the implant 73.5% TPNs and 50% TPNi (p = 0.341). Wound closure 91.2% with TPNs and 100% with TPNi (p = 1.000).</p><p><strong>Conclusions: </strong>The use of TPNs and TPNi were useful as adjuvant treatments in the management of IADO, in addition they allowed to preserve the implant and wound closure in a large part of the patients.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model. 抗血管生成剂 aflibercept 对手术诱发的大鼠子宫内膜异位症的影响。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000072
Caglayan Ates, Berna Dilbaz, Seval Yılmaz Ergani, Fuad Atabay
{"title":"The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model.","authors":"Caglayan Ates, Berna Dilbaz, Seval Yılmaz Ergani, Fuad Atabay","doi":"10.24875/CIRU.23000072","DOIUrl":"10.24875/CIRU.23000072","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study is to show for the first time how aflibercept affects endometriosis lesions.</p><p><strong>Material and methods: </strong>Surgically induced endometriosis in Wistar albino female rats. Rats with endometriosis were randomly divided into three groups: control (Co), aflibercept (Af), and leuprolide acetate (Le). Then, Af, aflibercept, and Le received leuprolide acetate. The control group was not treated. The weights and changes in intra-abdominal adhesions of the rats before and after treatment were recorded according to the Blauer adhesion score. Blood extracted for sacrifice was analyzed. Endometriotic lesions were evaluated for size, volume, histology, and immunohistochemistry (vascular endothelial growth factor [VEGF] and CD31). Significance level was accepted as p < 0.05.</p><p><strong>Results: </strong>Aflibercept significantly reduced endometrial implant volume (p = 0.002). The explant epithelial histological score showed a significant difference between aflibercept and leuprolide acetate (p = 0.006) and between aflibercept and control groups (p = 0.002). Aflibercept decreased VEGF-H and CD31 expression (p = 0.001) more than leuprolide acetate. Aflibercept improved adhesions (p = 0.006).</p><p><strong>Conclusion: </strong>Aflibercept is more successful than leuprolide acetate in the treatment of endometriosis.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for readmission after a cholecystectomy: a case-control study. 胆囊切除术后再次入院的风险因素:病例对照研究。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000057
Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño
{"title":"Risk factors for readmission after a cholecystectomy: a case-control study.","authors":"Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño","doi":"10.24875/CIRU.23000057","DOIUrl":"10.24875/CIRU.23000057","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to assess the risk factors associated with 30-day hospital readmissions after a cholecystectomy.</p><p><strong>Methods: </strong>We conducted a case-control study, with data obtained from UC-Christus from Santiago, Chile. All patients who underwent a cholecystectomy between January 2015 and December 2019 were included in the study. We identified all patients readmitted after a cholecystectomy and compared them with a randomized control group. Univariate and multivariate analyses were conducted to identify risk factors.</p><p><strong>Results: </strong>Of the 4866 cholecystectomies performed between 2015 and 2019, 79 patients presented 30-day hospital readmission after the surgical procedure (1.6%). We identified as risk factors for readmission in the univariate analysis the presence of a solid tumor at the moment of cholecystectomy (OR = 7.58), high pre-operative direct bilirubin (OR = 2.52), high pre-operative alkaline phosphatase (OR = 3.25), emergency admission (OR = 2.04), choledocholithiasis on admission (OR = 4.34), additional surgical procedure during the cholecystectomy (OR = 4.12), and post-operative complications. In the multivariate analysis, the performance of an additional surgical procedure during cholecystectomy was statistically significant (OR = 4.24).</p><p><strong>Conclusion: </strong>Performing an additional surgical procedure during cholecystectomy was identified as a risk factor associated with 30-day hospital readmission.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing complex decongestive therapy in patients with lymphedema of different causes by measuring: extremity volume, quality of life, and functionality. 通过测量肢体体积、生活质量和功能,比较不同原因引起的淋巴水肿患者的复合减充血疗法。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000330
Cansu Sahbaz-Pirincci, Emine Cihan, Ülkü Düzlü-Öztürk, Pınar Borman, Meltem Dalyan
{"title":"Comparing complex decongestive therapy in patients with lymphedema of different causes by measuring: extremity volume, quality of life, and functionality.","authors":"Cansu Sahbaz-Pirincci, Emine Cihan, Ülkü Düzlü-Öztürk, Pınar Borman, Meltem Dalyan","doi":"10.24875/CIRU.23000330","DOIUrl":"https://doi.org/10.24875/CIRU.23000330","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the effects of complex decongestive therapy (CDT) applied to the lower extremities of patients with lymphedema of different causes on the extremity volume, quality of life (QoL), and functionality.</p><p><strong>Materials and method: </strong>The study included 90 patients, of whom 28 had primary lymphedema, 30 had secondary lymphedema, 18 had phlebolymphedema, and 14 had lipolymphedema. A total of 137 extremities were treated with CDT. The patients who received CDT for 5 days a week for 3 weeks (15 sessions in total) were included in the sample. Extremity volume was measured using a tape measure. The lymphedema QoL-Leg Questionnaire was used to evaluate QoL, and the lower extremity functional scale (LEFS) was administered to assess lower extremity functionality.</p><p><strong>Results: </strong>The changes in QoL before and after treatment significantly differed in the primary lymphedema, phlebolymphedema, and lipolymphedema groups (p < 0.05). The post-treatment LEFS scores indicated a significant decrease in the phlebolymphedema and lipolymphedema groups compared to the pre-treatment scores (p < 0.05).</p><p><strong>Conclusions: </strong>The difference in appearance, which is one of the sub-parameters of QoL, significantly decreased in the comparisons performed between the groups, whereas the changes in the remaining parameters were not significant.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SynDaver® synthetic human cadaver: a 3D simulator for anatomy education and surgical training. SynDaver® 合成人体尸体:用于解剖教育和外科培训的三维模拟器。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.22000369
Manuel Uribe-Miranda
{"title":"SynDaver<sup>®</sup> synthetic human cadaver: a 3D simulator for anatomy education and surgical training.","authors":"Manuel Uribe-Miranda","doi":"10.24875/CIRU.22000369","DOIUrl":"https://doi.org/10.24875/CIRU.22000369","url":null,"abstract":"","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zidovudine, a brief history before the first antirretroviral in Mexico. 齐多夫定,墨西哥第一种抗逆转录病毒药物问世前的简史。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.22000250
Hans Malagón-Tejeida
{"title":"Zidovudine, a brief history before the first antirretroviral in Mexico.","authors":"Hans Malagón-Tejeida","doi":"10.24875/CIRU.22000250","DOIUrl":"https://doi.org/10.24875/CIRU.22000250","url":null,"abstract":"<p><p>In the 1980s in Mexico, that of the «moral renewal», there was the opening to the market and the manifestation of human immunodeficiency virus (HIV) and AIDS. In this writing, the historical and therapeutic conditions are related to alleviate the syndrome until the arrival of the first antiretroviral. It is a reconstruction of the events, of which the medical-social, main clinical manifestations and of course the pharmacological therapy, until de the development zidovudina or azidotimidina of AZT, the first antiretroviral to be approved. Nevertheless, in the Mexican context, this event wasn't decisive to significantly change the morbility and the mortality.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of clinical efficacy of different colon anastomosis methods in laparoscopic radical resection of colorectal cancer. 腹腔镜大肠癌根治术中不同结肠吻合方法的临床疗效比较
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000602
Weimin Sun, Jie Zhang
{"title":"Comparison of clinical efficacy of different colon anastomosis methods in laparoscopic radical resection of colorectal cancer.","authors":"Weimin Sun, Jie Zhang","doi":"10.24875/CIRU.23000602","DOIUrl":"https://doi.org/10.24875/CIRU.23000602","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to investigate the clinical effect of overlap anastomosis and functional end-to-end anastomosis (FEEA) in laparoscopic radical resection of colorectal cancer (CRC).</p><p><strong>Methods: </strong>The clinical data of 180 patients who underwent laparoscopic radical resection of CRC and side-to-side anastomosis were retrospectively collected; the patients were divided into the Overlap group and FEEA group, according to the anastomosis method that was used to treat them.</p><p><strong>Results: </strong>The Overlap group had a shorter operation time, anastomosis time, post-operative hospital stay, post-operative feeding time, and post-operative exhaust time than the FEEA group (p < 0.05). The total incidence of post-operative complications was 14.4% (13/90) in the FEEA group and 0.7% (6/90) in the Overlap group, and there was no significant difference between the two groups (p > 0.05).</p><p><strong>Conclusions: </strong>Overlapping anastomosis can shorten the operation time and accelerate the recovery of intestinal function without increasing the incidence of post-operative complications, and it will not affect the quality of life and survival of patients in the short term after surgery.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and urodynamics outcomes in pediatric primary bladder diverticula: a comparative study. 小儿原发性膀胱憩室的临床和尿动力学结果:一项比较研究。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000294
Birgül Karaaslan, Mehmet O Kuzdan
{"title":"Clinical and urodynamics outcomes in pediatric primary bladder diverticula: a comparative study.","authors":"Birgül Karaaslan, Mehmet O Kuzdan","doi":"10.24875/CIRU.23000294","DOIUrl":"10.24875/CIRU.23000294","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the effects of bladder diverticula smaller than 30 (SD) mm and larger than 30 mm (LD) on bladder functions and urodynamics.</p><p><strong>Materials and methods: </strong>Our retrospective analysis involved a cohort of 40 pediatric patients diagnosed with primary bladder diverticula.</p><p><strong>Results: </strong>The predicted mean bladder capacity (MBC) was 197.7 ± 95.8 mL, whereas the observed MBC was lower at an average of 170.1 ± 79.6 mL. This indicates that the observed MBC was 88.2 ± 12.9% of the predicted value (percentage). The mean diverticula diameter recorded was 33 ± 19.5 mm, and the diverticula to MBC ratio were calculated to be 0.25 ± 0.18. The distribution of urinary tract infections (UTIs) differed significantly between the groups (p < 0.001). Upper UT dilatation was significantly more common in the LD group (60%, n = 12) than in the SD group (15%, n = 3) (p = 0.003). The mean detrusor pressure (P[detrusor]) was significantly higher in the LD group (137.2 ± 24.1 cm H<sub>2</sub>O) than in the SD group (63.9 ± 5.8 cm H<sub>2</sub>O) (p = 0.001). In addition, the mean peak flow rate (Q<sub>max</sub>) was significantly higher in the SD group (20.7 ± 7.9 mL/s) compared to the LD group (12.7 ± 3.8 mL/s) (p < 0.001).</p><p><strong>Conclusion: </strong>Bladder diverticula size is a significant factor in the clinical presentation and management of primary bladder diverticula in pediatric patients.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of COVID-19 on pre-existing liver disease. COVID-19 对原有肝病的影响。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.23000409
Juan M Abdo-Francis, Rosalba Moreno-Alcantar, José L Pérez-Hernández, José M Remes-Troche, Antonio Velarde-Ruiz Velasco, Eira Cerda-Reyes, Fátima Higuera-de la Tijera, Graciela Castro-Narro
{"title":"Impact of COVID-19 on pre-existing liver disease.","authors":"Juan M Abdo-Francis, Rosalba Moreno-Alcantar, José L Pérez-Hernández, José M Remes-Troche, Antonio Velarde-Ruiz Velasco, Eira Cerda-Reyes, Fátima Higuera-de la Tijera, Graciela Castro-Narro","doi":"10.24875/CIRU.23000409","DOIUrl":"10.24875/CIRU.23000409","url":null,"abstract":"<p><p>Patients with chronic liver disease of any etiology who become infected with SARS-CoV-2 have been found to have a higher risk of mortality compared to those patients who do not have chronic liver disease. A literature review was conducted in the relationship between COVID 19 and preexistence of liver disease. The proportion of COVID-19 patients with abnormal liver function on admission ranged from 40 % to 75 % and the proportion with liver injury was close to 30%. Current studies show an important association between preexisting liver disease and COVID-19. The presence of cirrhosis is now an independent predictor of severity for COVID-19 and prolonged hospitalization in this group of patients. Patients with cirrhosis have a higher mortality rate, and this rate rises with increasing severity.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pentafecta evaluation in robot-assisted radical prostatectomy by risk group. 按风险组别对机器人辅助前列腺癌根治术中的 Pentafecta 进行评估。
Cirugia y cirujanos Pub Date : 2024-01-01 DOI: 10.24875/CIRU.22000583
Víctor E Corona-Montes, Juan E Sánchez-Núñez, Rocío N Gómez-López, Gerardo Fernández-Noyola
{"title":"Pentafecta evaluation in robot-assisted radical prostatectomy by risk group.","authors":"Víctor E Corona-Montes, Juan E Sánchez-Núñez, Rocío N Gómez-López, Gerardo Fernández-Noyola","doi":"10.24875/CIRU.22000583","DOIUrl":"10.24875/CIRU.22000583","url":null,"abstract":"<p><strong>Objective: </strong>Radical prostatectomy is a therapeutic option in organ-confined prostate cancer. As the development of robotic systems progresses, the approach with this technology has begun to impact the functional and oncological outcomes of urological patients. The objective is to report the rate of pentafecta in patients undergoing robot-assisted radical prostatectomy (RARP) stratified by risk groups.</p><p><strong>Method: </strong>Retrospective, observational, descriptive study from 2013 to 2020 that included 112 patients undergoing RARP.</p><p><strong>Results: </strong>A rate of pentafecta at 12 months of follow-up of 35.7% (n = 40) was obtained. In the subanalysis by risk groups, at 1-year follow-up, was obtained an index of 43% (n = 26), 26% (n = 9) and 22% (n = 4) in low-, intermediate-, and high-risk patients, respectively.</p><p><strong>Conclusions: </strong>Prostatectomy showed functional and oncological results similar to those reported in the literature with robotic approach, regardless of the risk group for prostate cancer.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信